Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vulnerability to extrapyramidal side effects

T Van Putten

    Clinical Neuropharmacology
    |January 1, 1983
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.

    Journal of psychiatry & neuroscience : JPN·1994
    Same author

    Simultaneous determination of plasma haloperidol and its metabolite reduced haloperidol by liquid chromatography with electrochemical detection. Plasma levels in schizophrenic patients treated with oral or intramuscular depot haloperidol.

    Journal of chromatography. B, Biomedical applications·1994
    Same author

    Optimal drug and behavior therapy for treatment-refractory schizophrenic patients.

    The American journal of psychiatry·1994
    Same author

    Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia.

    Archives of general psychiatry·1994
    Same author

    Radioimmunoassay for 7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in schizophrenic patients treated long term with oral and depot fluphenazine.

    Therapeutic drug monitoring·1994
    Same author

    Schizophrenia.

    The Psychiatric clinics of North America·1993
    Same journal

    Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.

    Clinical neuropharmacology·2026
    Same journal

    Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.

    Clinical neuropharmacology·2026
    Same journal

    Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

    Clinical neuropharmacology·2026
    Same journal

    A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.

    Clinical neuropharmacology·2026
    Same journal

    Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.

    Clinical neuropharmacology·2026
    Same journal

    Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.

    Clinical neuropharmacology·2026
    See all related articles